ResearcherMayo ClinicNo recent work listed
Naureen Javeed
Matched on ORCID iD 0000-0003-0833-9239; OpenAlex author ID A5070228740. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper
Papers 5
- Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2019.01.039↗
- Immunosuppressive CD14+HLA-DR lo/neg monocytes are elevated in pancreatic cancer and "primed" by tumor-derived exosomes. Co-author DOI 10.1080/2162402x.2016.1252013↗
- Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Co-author DOI 10.1136/gutjnl-2014-308350↗
- Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-cell Dysfunction. Co-author DOI 10.1158/1078-0432.ccr-14-2022↗
- Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. Co-author DOI 10.1053/j.gastro.2012.08.044↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Suresh T. Chari · 5 shared papers, 2012–2019 · strength 0.27
- Paper Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2019.01.039↗
- Paper Immunosuppressive CD14+HLA-DR lo/neg monocytes are elevated in pancreatic cancer and "primed" by tumor-derived exosomes. DOI 10.1080/2162402x.2016.1252013↗
- Paper Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. DOI 10.1136/gutjnl-2014-308350↗
- Debabrata Mukhopadhyay · 5 shared papers, 2012–2019 · strength 0.27
- Paper Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2019.01.039↗
- Paper Immunosuppressive CD14+HLA-DR lo/neg monocytes are elevated in pancreatic cancer and "primed" by tumor-derived exosomes. DOI 10.1080/2162402x.2016.1252013↗
- Paper Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. DOI 10.1136/gutjnl-2014-308350↗
- Gloria M. Petersen · 3 shared papers, 2012–2017 · strength 0.14
- Paper Immunosuppressive CD14+HLA-DR lo/neg monocytes are elevated in pancreatic cancer and "primed" by tumor-derived exosomes. DOI 10.1080/2162402x.2016.1252013↗
- Paper Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-cell Dysfunction. DOI 10.1158/1078-0432.ccr-14-2022↗
- Paper Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. DOI 10.1053/j.gastro.2012.08.044↗
- Raghuwansh P. Sah · 2 shared papers, 2016–2019 · strength 0.13
- Thomas C. Smyrk · 3 shared papers, 2012–2016 · strength 0.13
- Paper Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. DOI 10.1136/gutjnl-2014-308350↗
- Paper Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-cell Dysfunction. DOI 10.1158/1078-0432.ccr-14-2022↗
- Paper Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. DOI 10.1053/j.gastro.2012.08.044↗
- Gunisha Sagar · 2 shared papers, 2015–2016 · strength 0.10
- Ayush Sharma · 1 shared paper, 2019 · strength 0.07
- Aleksey V. Matveyenko · 1 shared paper, 2019 · strength 0.07
- Sneha Vivekanandhan · 1 shared paper, 2019 · strength 0.07
- Naoki Takahashi · 1 shared paper, 2019 · strength 0.07
- Sajan Jiv Singh Nagpal · 1 shared paper, 2019 · strength 0.07
- Michael J. Levy · 1 shared paper, 2019 · strength 0.07
- Ann L. Oberg · 1 shared paper, 2017 · strength 0.07
- Santanu Bhattacharya · 1 shared paper, 2015 · strength 0.05
- Mark Joseph Truty · 1 shared paper, 2015 · strength 0.05
- Thiruvengadam Arumugam · 1 shared paper, 2012 · strength 0.02
- Gaurav Aggarwal · 1 shared paper, 2012 · strength 0.02
- Vijaya Ramachandran · 1 shared paper, 2012 · strength 0.02
- Craig D. Logsdon · 1 shared paper, 2012 · strength 0.02
- Martín E. Fernández-Zapico · 1 shared paper, 2012 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.